TCL Archive Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned March 17, 1995
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005